title: A phase I/II trial of epirubicin and high dose tamoxifen as a potential modulator of multidrug resistance in advanced hepatocellular carcinoma.
authors.forename: M
authors.initials: M
authors.lastname: Raderer
authors.forename: J
authors.initials: J
authors.lastname: Pidlich
authors.forename: C
authors.initials: C
authors.lastname: Müller
authors.forename: F
authors.initials: F
authors.lastname: Pfeffel
authors.forename: G V
authors.initials: GV
authors.lastname: Kornek
authors.forename: M
authors.initials: M
authors.lastname: Hejna
authors.forename: W
authors.initials: W
authors.lastname: Scheithauer
mesh_terms: D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D006528:Carcinoma, Hepatocellular / Q000188:drug therapy*; D018432:Drug Resistance, Multiple; D019008:Drug Resistance, Neoplasm; D015251:Epirubicin / Q000008:administration & dosage; D005260:Female; D006801:Humans; D008113:Liver Neoplasms / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D013629:Tamoxifen / Q000008:administration & dosage
chemical_list: D013629:Tamoxifen; D015251:Epirubicin